by In2Pharma | Mar 28, 2023 | News
Belgium As from the start of 2023, a new system for funding market surveillance of medical devices by FAMHP applies. Unlike before, this will no longer be limited to the sale of medical devices to retailers and end users. All actors that carry out an activity...
by In2Pharma | Mar 22, 2023 | News
Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...
by In2Pharma | Mar 20, 2023 | News
Belgium The FAMHP would like to remind the pharmaceutical industry regarding the following topics: Pictograms related to the environment and recycling (e.g. green dot pictogram) do not comply with art.56§1 of the Royal Decree on medicines. The current guideline...
by In2Pharma | Dec 22, 2022 | News
Europe The European Commission had published an update of the Guidance document describing the food categories in Part E of Annex II to Regulation (EC) No 1333/2008 on Food Additives. In this new version the following changes are made: – update of Category 17,...
by In2Pharma | Dec 22, 2022 | News
Belgium Most important is the increase of hospitality that can be provided to healthcare professionals. The maximum amount for a lunch will be increased to 45€, for a dinner to 90€. A total maximum of 135€/day may be offered as hospitality to HCPs in the context of at...